bioRxivBioinformaticsPreprint
Identifying commonalities between cell lines and tumors at the single cell level using Sobolev Alignment of deep generative models
Soufiane M. C. MourraguiiD, Joseph C. SiefertiD, Marcel J. T. ReindersiD, Marco LoogiD, Lodewyk F.A. WesselsiD
Abstract
Preclinical models are essential to cancer research, however, key biological differences with patient tumors result in reduced translatability to the clinic and high attrition rates in drug development. Variability among and between patients, preclinical models, and individual cells obscures commonalities which could otherwise be exploited therapeutically. To discover the shared biological processes between cell line models and clinical tumors we developed Sobolev Alignment, a computational framework which uses deep generative models to capture non-linear processes in single-cell RNA sequencing data and kernel methods to align and interpret these processes. We show that our approach faithfully captures shared processes on a set of three synthetic datasets. Exploiting two large panels of untreated non-small cell lung cancer cell lines and patients, we identify the similarities between cell lines and tumors and show the conservation of key mitotic and immune-related pathways. Employing our approach on a large in-vitro perturbation screen, we show that processes captured by our method faithfully recapitulate the known modes of action of clinically approved drugs and allow investigation into the mode of action of an uncharacterized drug.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: deep learning
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Global computational alignment of tumor and cell line transcriptional profiles
A. Warren, A. Jones, … J. M. McFarland·bioRxiv·Mar 25, 2020
- Finding the best cell lines across pan-cancer to use in pre-clinical research as a proxy for patient tumor samples considering immune cells, multi-omics, and cancer pathways
Banabithi Bose, Serdar Bozdag·bioRxiv·Dec 18, 2022
- Comparing cancer cell lines and tumor samples by genomic profiles
Rileen Sinha, Nikolaus Schultz, Chris Sander·bioRxiv·Oct 2, 2015
- CTDPathSim: Cell line-tumor deconvoluted pathway-based similarity in the context of precision medicine in cancer
Banabithi Bose, Serdar Bozdag·bioRxiv·Jun 13, 2020
- Biologically relevant integration of transcriptomics profiles from cancer cell lines, patient-derived xenografts and clinical tumors using deep learning
Slavica Dimitrieva, Rens Janssens, … Eric Y. Durand·Science AdvancesPeer-reviewed·Jan 17, 2025
- Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq
Coral Fustero Torre, María José Jiménez‐Santos, … Fátima Al‐Shahrour·Genome MedicinePeer-reviewed·Dec 1, 2021